Stockreport

Annovis Bio Appoints Matthew Peterson, Ph.D., as Senior Clinical Scientist

Annovis Bio, Inc.  (ANVS) 
PDF MALVERN, Pa., Nov. 07, 2024 (GLOBE NEWSWIRE) -- via IBN -- Annovis Bio Inc. (NYSE: ANVS) ("Annovis" or the "Company"), a late-stage clinical drug platform company deve [Read more]